Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy

Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy

Albumin–bilirubin (ALBI) grade is an objective and reproducible model for evaluating overall survival (OS) in patients with hepatocellular carcinoma (HCC). However, the original ALBI grade was established for patients with Child–Pugh classes A–C. HCC patients with Child–Pugh class C or poor performa...

Full description

Bibliographic Details
Main Authors: Wei-Fan Hsu, Shih-Chao Hsu, Te-Hong Chen, Chien-Hung Lin, Ying-Chun Lin, Yu-Wei Chang, Hung-Wei Wang, Yu-Min Liao, Hsueh-Chou Lai, Cheng-Yuan Peng
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
albumin–bilirubin (ALBI) grade
curative therapy
hepatocellular carcinoma
modified ALBI grade
survival
Online Access:https://www.mdpi.com/2072-6694/14/20/5083

Internet

https://www.mdpi.com/2072-6694/14/20/5083

Similar Items